-
121
-
122
Heme alters biofilm formation in Mycobacterium abscessus
Published 2025-02-01“…ABSTRACT Mycobacterium abscessus (Mabs) is commonly found in the cystic fibrosis (CF) lung. During infection, Mabs can form biofilms in the lung which reduce both the ability of the immune response to clear infection and the effectiveness of antibiotic therapy. …”
Get full text
Article -
123
Prevalence and features of allergic bronchopulmonary aspergillosis, United States, 2016-2022.
Published 2025-01-01“…To estimate national ABPA prevalence among patients with asthma or cystic fibrosis, characterize ABPA testing practices, and describe ABPA clinical features, treatment, and 6-month outcomes. …”
Get full text
Article -
124
Immunopathology of Airway Surface Liquid Dehydration Disease
Published 2019-01-01“…Defective MCC is often associated with airway mucoobstruction, increased occurrence of respiratory infections, and progressive decrease in lung function in mucoobstructive lung diseases including cystic fibrosis (CF). In this disease, a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene results in dehydration of the airway surface liquid (ASL) layer. …”
Get full text
Article -
125
Heterogeneity of Clostridioides difficile asymptomatic colonization prevalence: a systematic review and meta-analysis
Published 2025-01-01“…Our meta-regression analysis revealed lower rates in healthy individuals and higher rates in cystic fibrosis patients and studies from North America. …”
Get full text
Article -
126
Chronic Disease Management in Children Based on the Five Domains of Health
Published 2013-01-01“…Through a case study of a child with cystic fibrosis, the interactions among various domains of health have been discussed—namely, biomedical, physical, psychological/behavioural, and social. …”
Get full text
Article -
127
Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro
Published 2001-01-01“…Background: Long-term administration of macrolide antibiotics is recognized to be able to favorably modify the clinical condition of inflammatory diseases, such as diffuse panbronchiolitis and cystic fibrosis. However, the precise mechanisms by which macrolide antibiotics could improve clinical conditions of the patients are not well understood.…”
Get full text
Article -
128
Newborn Screening Saves Lives but Cannot Replace the Need for Clinical Vigilance
Published 2018-01-01“…Newborn screening for cystic fibrosis (CF) enables early diagnosis and treatment leading to improved health outcomes for patients with CF. …”
Get full text
Article -
129
Glutamine Supplementation in Sick Children: Is It Beneficial?
Published 2011-01-01“…This includes premature infants, infants with gastrointestinal disease, children with Crohn's disease, short bowel syndrome, malnutrition/diarrhea, cancer, severe burns/trauma, Duchenne muscular dystrophy, sickle cell anemia, cystic fibrosis, and type 1 diabetes. Moreover, methodological issues have been noted in some studies. …”
Get full text
Article -
130
Autophagy in Inflammatory Diseases
Published 2011-01-01“…Furthermore, autophagy-dependent mechanisms have been proposed in the pathogenesis of several pulmonary diseases that involve inflammation, including cystic fibrosis and pulmonary hypertension. Strategies aimed at modulating autophagy may lead to therapeutic interventions for diseases associated with inflammation.…”
Get full text
Article -
131
CLINICAL PATTERNS OF MALABSORPTION SYNDROMES IN CHILDREN
Published 2024-12-01“…Celiac disease (51%), cystic fibrosis (32%), and Cow’s milk protein allergy (17%) were the leading causes. …”
Get full text
Article -
132
Meconium Peritonitis and Periorchitis: Report of a Prenatal Case
Published 2014-12-01“…Meconium peritonitis may also be caused by viral infections (cytomegalovirus or parvovirus B19) and cystic fibrosis. Here, we report of a patient with fetal meconium peritonitis - periorchitis and perinatal management. …”
Get full text
Article -
133
Recent Developments in Sweat Analysis and Its Applications
Published 2015-01-01“…Moreover, sweat comprises various biomarkers of different diseases including cystic fibrosis and diabetes. Additionally, the normalization of sampled volume of sweat is also necessary for getting efficient and useful results.…”
Get full text
Article -
134
Colistin: The phoenix Arises
Published 2006-01-01“…As a result, the use of polymyxin preparations has been mainly restricted to the treatment of lung infections due to multidrug-resistant (MDR) gram-negative bacteria in patients with cystic fibrosis (6,7). The emergence of bacteria resistant to most classes of commercially available antibiotics and the shortage of novel antimicrobial agents with activity against gram-negative microorganisms have led to the reemergence of polymyxins as a valuable addition to the therapeutic armamentarium. …”
Get full text
Article -
135
Study of Query Expansion Techniques and Their Application in the Biomedical Information Retrieval
Published 2014-01-01“…A corpus belonging to MEDLINE, called Cystic Fibrosis, is used as a knowledge source. Experimental results show that the proposed combinations of techniques greatly enhance the efficiency obtained by traditional queries.…”
Get full text
Article -
136
Inhalation Techniques Used in Patients with Respiratory Failure Treated with Noninvasive Mechanical Ventilation
Published 2018-01-01“…The administration of aerosolized medication is a basic therapy for patients with numerous respiratory tract diseases, including obstructive airway diseases (OADs), cystic fibrosis (CF), and infectious airway diseases. …”
Get full text
Article -
137
Burkholderia cepacia Complex: Emerging Multihost Pathogens Equipped with a Wide Range of Virulence Factors and Determinants
Published 2011-01-01“…Bcc bacteria are endowed with an extraordinary metabolic diversity and emerged in the 1980s as life-threatening and difficult-to-treat pathogens among patients suffering from cystic fibrosis. More recently, these bacteria became recognized as a threat to hospitalized patients suffering from other diseases, in particular oncological patients. …”
Get full text
Article -
138
A Case Report of Pulmonary Exacerbation after Initiation of Lumacaftor/Ivacaftor Therapy in a CF Female with Complicated Lung Disease
Published 2018-01-01“…Novel targeted treatments for Cystic Fibrosis give rise to new hope for an ever-growing number of CF patients with various mutations. …”
Get full text
Article -
139
Clinical benefits and risks of remote patient monitoring: an overview and assessment of methodological rigour of systematic reviews for selected patient groups
Published 2025-01-01“…For four patient groups (children with complex needs, children with cystic fibrosis, specialist maternity care, and sleep apnea), systematic reviews of adequate quality concluded that scientific evidence on clinical patient benefits of remote monitoring is very limited. …”
Get full text
Article -
140